Behind the Scenes of Elysium Health

Elysium Health is a health company  that was founded in 2014. Dr. Leonard Guarente is the co-founder of the company. In addition to his responsibilities as chief scientist of Elysium Health, he serves as the director of the Paul F. Glenn Center for Biology of Aging Research at MIT. The company partners with scientists from prominent academic institutions such as the University of Oxford, Harvard University, and the University of Cambridge. The research of Elysium Health is spearheaded by the world-class scientists and clinicians on the company’s scientific advisory board. These scientists guide the direction of the company.

Elysium Health makes a daily supplement called Basis. This supplement is proven to increase  levels of NAD+ in our bodies. NAD+ is essential to hundreds of our cellular functions, including circadian rhythms, energy creation, and DNA health. As we age, our levels of NAD+ decline and those functions break down. By taking Basis, you can restore those levels back up and support your cellular well-being.

To ensure that Basis works as intended, Elysium Health put the supplement through a clinical trial. The trial divided 120 subjects into three groups. Group one took two capsules of Basis, which is the recommended daily dose of the supplement. Group two took four capsules of the supplement, which is double the recommended daily dose of Basis. Group three took a placebo. Those who took the recommended dose of Basis during the trial had their NAD+ levels increaseby an average of 40 percent and remain there for the duration of the trial. In order to ensure the most accurate results, the trial was double-blind and randomized.

Basis is sold through Elysium Health’s website. The company sells Basis in a variety of monthly subscriptions, as well as in individual jars. Each jar contains 60 capsules (the recommended daily intake is two capsules). A regular month-to-month subscription costs $50 each month. The most popular plan is the six-month subscription to Basis for $270, which breaks down to $45 per month. A one-year plan is $480, or $40 per month.

https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=318913187